DR LAL PATHLABS LT (LALPATHLAB.NS) Financials
LALPATHLAB.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 24.5 billion | 6.4 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 23.9 billion | 6.9 billion |
LALPATHLAB.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 720.0 million | ? |
| 2023-09-30 | 718.0 million | ? |
| 2023-06-30 | 702.0 million | ? |
| 2023-03-31 | 228.1 million | 228.1 million |
LALPATHLAB.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 813.0 million |
| 2023-09-30 | 1.1 billion |
| 2023-06-30 | 826.0 million |
| 2023-03-31 | 566.5 million |
LALPATHLAB.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 9.0 billion | - | - |
| 2023-09-30 | 9.3 billion | 1.7 billion | 1.7 billion |
| 2023-06-30 | 8.2 billion | - | - |
| 2023-03-31 | 8.5 billion | 2.1 billion | 1.8 billion |
LALPATHLAB.NS Shares Outstanding
LALPATHLAB.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | 777.0 million | 269.0 million |
| 2023-09-30 | 277.0 million | - | 852.0 million | 253.0 million |
| 2023-06-30 | - | - | 745.0 million | - |
| 2023-03-31 | 445.7 million | - | 688.3 million | 507.8 million |
LALPATHLAB.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 5.4 billion | 1.8 billion |
| 2023-09-30 | 6.0 billion | 2.1 billion |
| 2023-06-30 | 5.4 billion | 1.9 billion |
| 2023-03-31 | 4.9 billion | 1.1 billion |
LALPATHLAB.NS
Price: ₹2,549.25
Dividend Yield: 1.08%
Forward Dividend Yield: 0.94%
Payout Ratio: 60.64%
Dividend Per Share: 24.00 INR
Earnings Per Share: 39.72 INR
P/E Ratio: 61.07
Exchange: NSI
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 209.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 9
DGR3: 17.66%
DGR5: 30.00%